D-TAILS S.R.L. SB
DISRUPTIVE TECHNOLOGICAL ADVANCES IN LIFE SCIENCE S.R.L. - SOCIETA' BENEFIT
D-TAILS is dedicated to carryout research of disruptive technologies for early diagnosis of Alzheimer Disease and other neurodegenerative pathologies. New specific biocompatible marker are under development to detect Tau aggregates in the retina
New specific mass screening test on urine are under development for breast cancer, prostate cancer and pancreatic cancer. C-elegans is a subject of study for the specific behavior when exposed to VOCs.
Our imaging solutions include new super-resolution techniques, structured illumination, and adaptive optics.
Company Details
- Employees
- 12
- Founded
- 2022
- Address
- Via Di Torre Rossa, 66, Rome,latium 00165,italy
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.d-tails.com
- Keywords
- ROAD Project.
- HQ
- Rome, Latium
D-Tails Research Questions
D-Tails Research's website is http://www.d-tails.com
D-Tails Research's LinkedIn profile is https://it.linkedin.com/company/d-tails-research
D-Tails Research has
12 employees.
View email and phone details for 12
employees at D-Tails Research.
D-Tails Research's industry is
Biotechnology Research
D-Tails Research's top competitors are
Leonardo,
Clinica Digitale,
Aindo,
Crisel Instruments,
Atlas Evolution S.r.l,
Wholetech,
Innovit - Italian Innovation And Culture Hub,
Road Project,
Crestoptics,
D-Tails.
D-Tails Research's categories are Biotechnology Research
D-Tails Research's founding year is 2022
